1H-Benzimidazole, 2-[2-(2-furanyl)ethenyl]-1-(2-propen-1-yl)-, hydrochloride (1:1)

1H-Benzimidazole, 2-[2-(2-furanyl)ethenyl]-1-(2-propen-1-yl)-, hydrochloride (1:1) Suppliers list
Company Name: Shanghai YuanYe Biotechnology Co., Ltd.  
Tel: 15026964105
Email: 2881489226@qq.com
Company Name: TargetMol  
Tel: 400-821-0310 15002144251
Email: xuexiang.shao@tsbiochem.com
1H-Benzimidazole, 2-[2-(2-furanyl)ethenyl]-1-(2-propen-1-yl)-, hydrochloride (1:1) Basic information
Product Name:1H-Benzimidazole, 2-[2-(2-furanyl)ethenyl]-1-(2-propen-1-yl)-, hydrochloride (1:1)
Synonyms:1H-Benzimidazole, 2-[2-(2-furanyl)ethenyl]-1-(2-propen-1-yl)-, hydrochloride (1:1);WAY-323878-A;CDKI-IN-1
CAS:1185726-51-5
MF:C16H15ClN2O
MW:286.76
EINECS:
Product Categories:
Mol File:1185726-51-5.mol
1H-Benzimidazole, 2-[2-(2-furanyl)ethenyl]-1-(2-propen-1-yl)-, hydrochloride (1:1) Structure
1H-Benzimidazole, 2-[2-(2-furanyl)ethenyl]-1-(2-propen-1-yl)-, hydrochloride (1:1) Chemical Properties
Safety Information
MSDS Information
1H-Benzimidazole, 2-[2-(2-furanyl)ethenyl]-1-(2-propen-1-yl)-, hydrochloride (1:1) Usage And Synthesis
UsesCDKI-IN-1 (Compound SNX12) is a cyclin-dependent kinase inhibitor (CDKI) inhibitor that can be used for research into degenerative diseases of the central nervous system[1].
References[1] Bey-Dih Chang, et al. Cdki pathway inhibitors and uses thereof. Patent, US20090281129. 2009-11-12.
1H-Benzimidazole, 2-[2-(2-furanyl)ethenyl]-1-(2-propen-1-yl)-, hydrochloride (1:1) Preparation Products And Raw materials
Tag:1H-Benzimidazole, 2-[2-(2-furanyl)ethenyl]-1-(2-propen-1-yl)-, hydrochloride (1:1)(1185726-51-5) Related Product Information
N-(5-(difluoromethoxy)-1H-pyrazol-3-yl)-1-((tetrahydro-2H-pyran-4-yl)methyl)-1H-pyrazolo[3,4-b]pyrazin-6-amine CDK12-CCNK HETERODIMER Protein, HUMAN (SF9) CDK3-CCNE1 HETERODIMER Protein, HUMAN (SF9) OTS964 hydrochloride GSK-3326595 DRB